Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma

miR-let-7a is a tumor suppressor miRNA with reduced expression in most cancers. Methylation of MIRLET7A3 gene was reported to be the cause of this suppression in several cancers; however, it was not explicitly investigated in Hepatocellular Carcinoma (HCC). We aimed at investigating miR-let-7a expre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Waly, Amr A. (VerfasserIn) , Breuhahn, Kai (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 January 2019
In: Frontiers in physiology
Year: 2019, Jahrgang: 9
ISSN:1664-042X
DOI:10.3389/fphys.2018.01918
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3389/fphys.2018.01918
Verlag, Volltext: https://www.frontiersin.org/articles/10.3389/fphys.2018.01918/full
Volltext
Verfasserangaben:Amr A. Waly, Nada El-Ekiaby, Reem A. Assal, Mohamed M. Abdelrahman, Karim A. Hosny, Hend M. El Tayebi, Gamal Esmat, Kai Breuhahn and Ahmed I. Abdelaziz

MARC

LEADER 00000caa a2200000 c 4500
001 1588256014
003 DE-627
005 20220815114802.0
007 cr uuu---uuuuu
008 190301s2019 xx |||||o 00| ||eng c
024 7 |a 10.3389/fphys.2018.01918  |2 doi 
035 |a (DE-627)1588256014 
035 |a (DE-576)518256014 
035 |a (DE-599)BSZ518256014 
035 |a (OCoLC)1341040652 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Waly, Amr A.  |e VerfasserIn  |0 (DE-588)1179803841  |0 (DE-627)1067475540  |0 (DE-576)518255964  |4 aut 
245 1 0 |a Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma  |c Amr A. Waly, Nada El-Ekiaby, Reem A. Assal, Mohamed M. Abdelrahman, Karim A. Hosny, Hend M. El Tayebi, Gamal Esmat, Kai Breuhahn and Ahmed I. Abdelaziz 
264 1 |c 24 January 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.03.2019 
520 |a miR-let-7a is a tumor suppressor miRNA with reduced expression in most cancers. Methylation of MIRLET7A3 gene was reported to be the cause of this suppression in several cancers; however, it was not explicitly investigated in Hepatocellular Carcinoma (HCC). We aimed at investigating miR-let-7a expression and molecular mode in HCC, identifying drug-targetable networks, which might be affected by its abundance. Our results illustrated a significant repression of miR-let-7a, which correlated with hypermethylation gene of origin MIRLRT7A3. This was further supported by the induction of miR-let-7a expression upon treatment of HCC cells with a DNA-methytransferase inhibitor. Using a computational approach, insulin-like growth factor (IGF)-II and IGF-2 mRNA binding proteins (IGF2BP)-2/-3 were identified as potential targets for miR-let-7a that was further confirmed experimentally. Indeed, miR-let-7a mimics diminished IGF-II as well as IGF2BP-2/-3 expression. In conclusion, this study suggests that DNA hypermethylation leads to epigenetic repression of miR-let-7a in HCC cells, which, induces the oncogenic IGF-signaling pathway. 
650 4 |a HCC (hepatocellular carcinoma) 
650 4 |a IGF-II 
650 4 |a IGF2BP/IMP 
650 4 |a Methylation 
650 4 |a miR-let-7a 
700 1 |a Breuhahn, Kai  |d 1969-  |e VerfasserIn  |0 (DE-588)122803329  |0 (DE-627)082164959  |0 (DE-576)293427364  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in physiology  |d Lausanne : Frontiers Research Foundation, 2007  |g 9(2019) Artikel-Nummer 01918, 10 Seiten  |h Online-Ressource  |w (DE-627)631498788  |w (DE-600)2564217-0  |w (DE-576)32655095X  |x 1664-042X  |7 nnas  |a Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma 
773 1 8 |g volume:9  |g year:2019  |a Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma 
856 4 0 |u http://dx.doi.org/10.3389/fphys.2018.01918  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fphys.2018.01918/full  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190301 
993 |a Article 
994 |a 2019 
998 |g 122803329  |a Breuhahn, Kai  |m 122803329:Breuhahn, Kai  |d 910000  |d 912000  |d 50000  |e 910000PB122803329  |e 912000PB122803329  |e 50000PB122803329  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 8 
999 |a KXP-PPN1588256014  |e 3057082238 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 01.03.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1588256014","relHost":[{"title":[{"title":"Frontiers in physiology","title_sort":"Frontiers in physiology"}],"pubHistory":["2007 -"],"part":{"year":"2019","text":"9(2019) Artikel-Nummer 01918, 10 Seiten","volume":"9"},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 24.05.23"],"disp":"Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinomaFrontiers in physiology","recId":"631498788","language":["eng"],"origin":[{"dateIssuedKey":"2007","publisher":"Frontiers Research Foundation","dateIssuedDisp":"2007-","publisherPlace":"Lausanne"}],"id":{"zdb":["2564217-0"],"eki":["631498788"],"issn":["1664-042X"]},"name":{"displayForm":["Frontiers Research Foundation"]},"physDesc":[{"extent":"Online-Ressource"}]}],"language":["eng"],"person":[{"given":"Amr A.","family":"Waly","role":"aut","display":"Waly, Amr A.","roleDisplay":"VerfasserIn"},{"family":"Breuhahn","given":"Kai","display":"Breuhahn, Kai","roleDisplay":"VerfasserIn","role":"aut"}],"name":{"displayForm":["Amr A. Waly, Nada El-Ekiaby, Reem A. Assal, Mohamed M. Abdelrahman, Karim A. Hosny, Hend M. El Tayebi, Gamal Esmat, Kai Breuhahn and Ahmed I. Abdelaziz"]},"title":[{"title":"Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma","title_sort":"Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma"}],"origin":[{"dateIssuedDisp":"24 January 2019","dateIssuedKey":"2019"}],"id":{"eki":["1588256014"],"doi":["10.3389/fphys.2018.01918"]}} 
SRT |a WALYAMRABRMETHYLATIO2420